| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX003 (ip) | median survival time | saline | 2.5 mg/kg/injection | 111.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 5.0 mg/kg/injection | 152.0 | Antitumor endpoint evaluated on day 60; 08/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 10.0 mg/kg/injection | 90.0 | Antitumor endpoint evaluated on day 60; 06/08 animals surviving on day 9 |
| Q04DX003 (ip) | median survival time | saline | 20.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 60; 00/07 animals surviving on day 9 |